NCT05736029View on ClinicalTrials.gov

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

January 1, 2028

Study Completion Date

June 30, 2028

Conditions
Non Small Cell Lung CancerHealthy
Interventions
OTHER

blood, stool and tissue samples collection

blood, stool and tissue samples collection before and during the treatment, as applicable

Trial Locations (1)

75204

RECRUITING

Baylor Scott and White Research Institute, Dallas

Sponsors

Lead Sponsor

OncoHost Ltd.
All Listed Sponsors
lead

OncoHost Ltd.

INDUSTRY

NCT05736029 - Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics | Biotech Hunter | Biotech Hunter